Literature DB >> 21918190

Regulatory T cells in patients with Whipple's disease.

Katina Schinnerling1, Verena Moos, Anika Geelhaar, Kristina Allers, Christoph Loddenkemper, Julian Friebel, Kristina Conrad, Anja A Kühl, Ulrike Erben, Thomas Schneider.   

Abstract

Classical Whipple's disease (CWD) is caused by chronic infection with Tropheryma whipplei that seems to be associated with an underlying immune defect. The pathognomonic hallmark of CWD is a massive infiltration of the duodenal mucosa with T. whipplei-infected macrophages that disperse systemically to many other organ systems. An alleviated inflammatory reaction and the absence of T. whipplei-specific Th1 reactivity support persistence and systemic spread of the pathogen. In this article, we hypothesized that regulatory T cells (T(reg)) are involved in immunomodulation in CWD, and we asked for the distribution, activation, and regulatory capacity of T(reg) in CWD patients. Whereas in the lamina propria of CWD patients before treatment numbers of T(reg) were increased, percentages in the peripheral blood were similar in CWD patients and healthy controls. However, peripheral T(reg) of CWD patients were more activated than those of controls. Elevated secretion of IL-10 and TGF-β in the duodenal mucosa of CWD patients indicated locally enhanced T(reg) activity. Enhanced CD95 expression on peripheral memory CD4(+) T cells combined with reduced expression of IFN-γ and IL-17A upon polyclonal stimulation by CD4(+) cells from untreated CWD patients further hinted to T(reg) activity-related exhaustion of effector CD4(+) T cells. In conclusion, increased numbers of T(reg) can be detected within the duodenal mucosa in untreated CWD, where huge numbers of T. whipplei-infected macrophages are present. Thus, T(reg) might contribute to the chronic infection and systemic spread of T. whipplei in CWD but in contrast prevent mucosal barrier defect by reducing local inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918190     DOI: 10.4049/jimmunol.1101349

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Whipple's Disease: Diagnostic Value of rpoB Gene PCR from Peripheral Blood Mononuclear Cells.

Authors:  Kathleen Weigt; Alexandra Wiessner; Annette Moter; Florence Fenollar; Didier Raoult; Kristina Allers; Thomas Schneider; Verena Moos
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

2.  Inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of bovine herpesvirus 1 in a DNA vaccine modulates immune responses of mice and cattle.

Authors:  Sarah Mackenzie-Dyck; Jennifer Kovacs-Nolan; Marlene Snider; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

3.  Cytokine genetic profile in Whipple's disease.

Authors:  F Biagi; C Badulli; G E Feurle; C Müller; V Moos; T Schneider; T Marth; J Mytilineos; F Garlaschelli; A Marchese; L Trotta; P I Bianchi; M Di Stefano; A L Cremaschi; A De Silvestri; L Salvaneschi; M Martinetti; G R Corazza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-31       Impact factor: 3.267

Review 4.  Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections.

Authors:  Ruben A V Dolmans; C H Edwin Boel; Miangela M Lacle; Johannes G Kusters
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

5.  Role of dendritic cells in the pathogenesis of Whipple's disease.

Authors:  Katina Schinnerling; Anika Geelhaar-Karsch; Kristina Allers; Julian Friebel; Kristina Conrad; Christoph Loddenkemper; Anja A Kühl; Ulrike Erben; Ralf Ignatius; Verena Moos; Thomas Schneider
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

6.  Peripheral T-Cell Reactivity to Heat Shock Protein 70 and Its Cofactor GrpE from Tropheryma whipplei Is Reduced in Patients with Classical Whipple's Disease.

Authors:  Lucia Trotta; Kathleen Weigt; Katina Schinnerling; Anika Geelhaar-Karsch; Gerrit Oelkers; Federico Biagi; Gino Roberto Corazza; Kristina Allers; Thomas Schneider; Ulrike Erben; Verena Moos
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

7.  Role of LFA-1 in the activation and trafficking of T cells: implications in the induction of chronic colitis.

Authors:  Iurii Koboziev; Fridrik Karlsson; Dmitry V Ostanin; Laura Gray; Melissa Davidson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2012-04-05       Impact factor: 5.325

8.  Architectural and functional alterations of the small intestinal mucosa in classical Whipple's disease.

Authors:  H-J Epple; J Friebel; V Moos; H Troeger; S M Krug; K Allers; K Schinnerling; A Fromm; B Siegmund; M Fromm; J D Schulzke; T Schneider
Journal:  Mucosal Immunol       Date:  2017-02-08       Impact factor: 7.313

9.  Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study.

Authors:  Jamie Ann Elchert; Emad Mansoor; Mohannad Abou-Saleh; Gregory S Cooper
Journal:  Dig Dis Sci       Date:  2018-11-28       Impact factor: 3.199

Review 10.  Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes.

Authors:  Caoimhe Egan; Elaine S Jaffe
Journal:  Semin Diagn Pathol       Date:  2017-11-03       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.